|
Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model. |
| |
|
Research Funding - TriSalus Life Sciences |
| |
Jayanth Shankara Narayanan |
Research Funding - TriSalus Life Sciences |
| |
|
Research Funding - TriSalus Life Sciences |
| |
|
Employment - TriSalus Life Sciences |
Research Funding - TriSalus Life Sciences |
| |
|
Employment - TriSalus Life Sciences |
Research Funding - TriSalus Life Sciences |
| |
|
Employment - TriSalus Life Sciences |
Leadership - TriSalus Life Sciences |
Research Funding - TriSalus Life Sciences |
| |
|
Employment - TriSalus Life Sciences |
Leadership - TriSalus Life Sciences |
Research Funding - TriSalus Life Sciences |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - TriSalus Life Sciences |